Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of cerebral palsy in preterm infants
2017-004898-14Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of magnesium sulfate in cerebral palsy (CP) and neurologic injury, sponsored by Sahlgrenska University Hospital. Started Feb 2018; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
cerebral palsy (CP)neurologic injury
Beyond the preview
Go deeper on 2017-004898-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004898-14.